FDA Panel Advisor Who Panned New Alzheimer ' s Drug Speaks Out

WEDNESDAY, July 28, 2021 -- An outside advisor to the U.S. Food and Drug Administration ' s review of the controversial Alzheimer ' s drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news